Canadian Collaborative Research Network
N

EMPACT-MI – Does Empagliflozin Improve Outcomes After Acute MI?

By Canadian Collaborative Research Network FEATURING Narendra Singh
By Canadian Collaborative Research Network FEATURING Narendra Singh
75 views
August 20, 2024
0 Comments
Login to view comments. Click here to Login

Featured Video

32:56
Terumo Interventional Systems

Elevating Cardiac Care: Insights from ePRISM in the Cath Lab | Terum…

Feat. N. Reddy

Featured Video

15:01
Lilly Diabetes

Discover the MOA of an Incretin Medication for T2D

Related Content

AUTOPLAY
64:45
Symposium on Diabetes and Cancer 2017: Novel Links and Treatments

Primer on Diabetes Management

Feat. S. Inzucchi
11:37
ACC 2022 Conference Coverage

ACC 2022: An Embarrassment of Riches - Updated Guideline Recommendat…

Feat. P. Heidenreich
11:25
ACC 2023 Conference Coverage

ACC 2023: SGLT2i Use - Dos and Don'ts

Feat. A. Armbruster
27:14
MUSC Cardiology

Which Diuretic(s) Are Best in HF? Update Based on Recent Clinical Tr…

Feat. R. Mentz
18:43
ASPC 2019 Congress on CVD Prevention

Diabetes Treatment Guidelines Finally Have Entered the 21st Century …

Feat. R. DeFronzo
26:01
Cardiology Fiesta 2017

Renal, Metabolic and Cardiovascular Considerations of SGLT2 Inhibiti…

Feat. R. DeFronzo
17:44
Rita Jermyn

SGLT2 Inhibitors: For Heart Failure, Diabetes, and Renal Disease

27:24
Cardiometabolic Health Congress (CMHC)

SGLT2 Inhibitors, GLP1 Receptor Agonists, and Renal Outcomes

Feat. L. Sloan
61:49
Obafemi Awolowo University

Management of Heart Failure

Feat. O. A. Akinyele
09:52
AHA 2022 Conference Coverage

AHA 2022: Torsemide Comparison With Furosemide for Management of Hea…

Feat. R. Mentz
13:07
Michelle Kittleson

2021 ADA Highlights: Heart Failure With Reduced Ejection Fraction - …

40:49
University of Minnesota

ECMO for Refractory Cardiac Arrest: Mobile MN Community Efforts and …

Feat. D. Yannopoulos
07:22
Canadian Collaborative Research Network

TACT2 – Does Chelation Reduce Events in Diabetic Post-MI Patients?

Feat. N. Singh
35:16
Scripps Health

HFpEF or Amyloidosis? The Right Therapies for Right Patients

Feat. M. Kittleson
17:14
Craig Beavers

Managing Iron Deficiency in Heart Failure: Recognizing the Need for …

12:12
CVRx | Barostim

Challenges and Opportunities with Contemporary GDMT in NYHA Class II…

Feat. W. Abraham
28:48
MUSC Cardiology

Weight Loss as Treatment for HFpEF: An Update on Drugs and Procedures

Feat. S. Litwin
11:29
The 9th Annual Western New England Acute Cardiology Conference

Esmolol in Refractory VF

Feat. B. Hoffman
19:30
ACC 2022 Conference Coverage

Hot Topics in Heart Failure ACC.22

Feat. N. Ibrahim
12:30
Houston Methodist Hospital

Amyloidosis Types and Pathophysiology

Feat. B. Trachtenberg